Can BioMarin (BMRN) Turn Margin Ambitions Into Strength Amid Rising Rare-Disease Competition? [Yahoo! Finance]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Yahoo! Finance
outlined a target of reaching a 40% non-GAAP operating margin next year while sharpening its focus on genetically defined rare conditions. At the same time, an analyst downgrade highlighted concerns about rising competition in achondroplasia and gaps in BioMarin's pipeline, even as the company pursues margin improvement, restructurings, and the Inozyme acquisition to reshape its portfolio. Next, we'll examine how the analyst downgrade and competitive concerns interact with BioMarin's margin goals to reshape its investment narrative. The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 25 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. To own BioMarin today, you need to believe its refocus on genetically defined rare diseases and a 40% non GAAP operating margin target can offset rising comp
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- Is The Market Mispricing BioMarin After Its Multi Year Share Price Slump In 2025 [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical (BMRN) Valuation Check After This Year's 20% Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical Inc. (BMRN) Outlook Lowered By Leerink [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical Inc. (BMRN): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical (NASDAQ:BMRN) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $60.00 price target on the stock, down previously from $82.00.MarketBeat
BMRN
Earnings
- 10/27/25 - Miss
BMRN
Sec Filings
- 12/2/25 - Form 4
- 11/14/25 - Form SCHEDULE
- 10/28/25 - Form 10-Q
- BMRN's page on the SEC website